Shield Therapeutics: Peer Teva Pharmaceutical Industries Withdraws Oppositions to Patents
By Matteo Castia
Shield Therapeutics PLC said Monday that competitor Teva
Pharmaceutical Industries Ltd. has withdrawn all its oppositions
against the company's patents.
"Teva has withdrawn both its appeal against the European Patent
Office's decision with regard to Shield's patent number 2668175,
which covers a 'process for preparing an iron hydroxypyrone' and
their opposition with regard to Shield's patent number 3160951
which covers 'crystalline forms of ferric maltol," the
pharmaceutical company said.
This means that both patents are maintained and will continue to
provide protection, Shield said.
Write to Matteo Castia at email@example.com
(END) Dow Jones Newswires
October 19, 2020 02:59 ET (06:59 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.